F. Stögbauer

M. Nöthen, M. Gratacós, L. Armengol, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Treatment for Charcot-Marie-Tooth disease.

P. de Jonghe, P. Jonghe, Peter De Jonghe, 2008, The Cochrane database of systematic reviews.

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.

H. Hartung, R. Gold, A. Chan, 2015, JAMA neurology.

Lumbar spinal neurinoma presenting with nocturnal pain. A case report.

C. Schul, F. Stögbauer, M. Oelerich, 1998, Clinical imaging.

Brachial plexus involvement as the only expression of hereditary neuropathy with liability to pressure palsies

K. Ørstavik, F. Stögbauer, P. Young, 2001, Muscle & nerve.

Clinical and genetic variability of oculodentodigital dysplasia

U. Grasshoff, M. Schwaninger, C. Grond-Ginsbach, 2006, Clinical genetics.

Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort

U. John, C. Kessler, E. Ringelstein, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Neurologische Manifestationen der HIV-1-Infektion/Aids

G. Schuierer, S. Evers, I. Husstedt, 1998 .

A novel technique for identification of doppler microembolic signals based on the coincidence method: in vitro and in vivo evaluation.

E B Ringelstein, E. Ringelstein, D. Nabavi, 1996, Stroke.

Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate

P. Lüdemann, F. Stögbauer, F. Bethke, 2000, Journal of Neurology.

Genetic refinement of the hereditary neuralgic amyotrophy (HNA) locus at chromosome 17q25

C. Broeckhoven, J. Meuleman, E. Airaksinen, 1999, European Journal of Human Genetics.

Incidence and Risk Factors for Stroke in an Occupational Cohort The PROCAM Study

G. Assmann, H. Schulte, K. Berger, 1998 .

[Meralgia paresthetica. A rare differential diagnosis of circumscribed alopecia].

D. Nabavi, D. Georgiadis, F. Stögbauer, 1996, Deutsche medizinische Wochenschrift.

Electromagnetic fields (GSM 1800) do not alter blood–brain barrier permeability to sucrose in models in vitro with high barrier tightness

H. Galla, Helmut Franke, F. Stögbauer, 2005, Bioelectromagnetics.

Cervical artery dissection—clinical features, risk factors, therapy and outcome in 126 patients

E. Ringelstein, S. Evers, B. Dräger, 2003, Journal of Neurology.

Recurrent brachial plexus palsies as the only clinical expression of hereditary neuropathy with liability to pressure palsies associated with a de novo deletion of the peripheral myelin protein‐22 gene

G. Assmann, H. Funke, M. Kerschensteiner, 1998, Muscle & nerve.

Thirty-seven CAG repeats in the androgen receptor gene in two healthy individuals

E. Ringelstein, G. Kuhlenbäumer, W. Kress, 2001, Journal of Neurology.

The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case–control studies

U. John, C. Kessler, Suzanne Cheng, 2007, Human Genetics.

Chromaffin Cells: A Novel Source for Neuronotrophic Factors

K. Unsicker, R. Lietzke, F. Stögbauer, 1987 .

Electromagnetic fields (1.8 GHz) increase the permeability to sucrose of the blood-brain barrier in vitro.

A. Schirmacher, H. Galla, F. Stögbauer, 2000, Bioelectromagnetics.

Genetic association of Huntington's disease and restless legs syndrome? A family report

S. Evers, F. Stögbauer, 2003, Movement disorders : official journal of the Movement Disorder Society.

Side matters: differences in functional outcome and quality of life after thrombectomy in left and right hemispheric stroke

C. Gerloff, C. Nolte, G. Hamann, 2022, Neurological Research and Practice.

[X-chromosomal recessive spinobulbar muscular atrophy (Kennedy type). Description of a family, clinical aspects, molecular genetics, differential diagnosis and therapy].

G. Kuhlenbäumer, C. Oberwittler, W. Kress, 1998, Der Nervenarzt.

Hereditary Peripheral Neuropathies

E. Ringelstein, G. Kuhlenbäumer, F. Stögbauer, 2005 .

Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells.

O. Schober, M. Weckesser, K. Kopka, 1999, European journal of nuclear medicine.

Kinetics of 3-[123I]iodo-l-α-methyltyrosine transport in rat C6 glioma cells

O. Schober, M. Weckesser, K. Kopka, 1999, European Journal of Nuclear Medicine.

Kinetic parameters of 3-[(123)I]iodo-L-alpha-methyl tyrosine ([(123)I]IMT) transport in human GOS3 glioma cells.

O. Schober, C. Franzius, M. Weckesser, 2001, Nuclear Medicine and Biology.

Autosomal dominant striatal degeneration (ADSD)

M. Hund-Georgiadis, C. van Broeckhoven, G. Schuierer, 2004, Neurology.

A case of adrenomyeloneuropathy with unusual lesion pattern in magnetic resonance imaging

I. Husstedt, R. Dziewas, M. Ritter, 2001, Journal of Neurology.

Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b.

P. Lüdemann, F. Stögbauer, F. Bethke, 1999, Neurology.

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Alexander Parajeles Vindas, P. Kowey, D. Arnold, 2016, Neurology. Clinical practice.

Risk factors for pneumonia in patients with acute stroke.

R. Dziewas, P. Lüdemann, F. Stögbauer, 2003, Stroke.

Long-term TherapyWith Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica SpectrumDisorder

H. Hartung, R. Gold, A. Chan, 2015 .

PMP22 frameshift mutation and hereditary neuropathy with liability to pressure palsies

G. Assmann, H. Wiebusch, H. Funke, 1997, Neurology.

Refinement of the hereditary neuralgic amyotrophy (HNA) locus to chromosome 17q24–q25

C. Broeckhoven, V. Timmerman, G. Kurlemann, 1997, Human Genetics.

Endovascular thrombectomy for basilar artery occlusion stroke: Analysis of the German Stroke Registry‐Endovascular Treatment

M. Wiesmann, C. Gerloff, C. Nolte, 2023, European journal of neurology.

Machine Learning–Based Identification of Target Groups for Thrombectomy in Acute Stroke

J. Mocco, C. Gerloff, C. Nolte, 2022, Translational Stroke Research.

Late Thrombectomy in Clinical Practice

M. Wiesmann, C. Gerloff, M. Dichgans, 2021, Clinical Neuroradiology.

Treatment of status epilepticus in a large community hospital

C. Kellinghaus, F. Stögbauer, 2012, Epilepsy & Behavior.

Late onset postpartum eclampsia: a rare and difficult diagnosis

R. Dziewas, M. Freund, P. Lüdemann, 2002, Journal of Neurology.

Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor

A. Barnekow, H. Halfter, F. Stögbauer, 1998, Journal of Neuro-Oncology.

Generalized arteriopathy in patients with cervical artery dissection

E. Ringelstein, D. Nabavi, S. Evers, 2005, Neurology.

Stroke Syndromes: Borderzone infarcts

R. Dittrich, F. Stögbauer, E. Ringelstein, 2012 .

The natural history of hereditary neuralgic amyotrophy in the Dutch population.

B. Engelen, J. Meuleman, B. Falck, 2000 .

Genomic organization and mutation analysis of three candidate genes for hereditary neuralgic amyotrophy

J. Meuleman, P. Chance, V. Timmerman, 2004, Muscle & nerve.

Novel APP mutation V715A associated with presenile Alzheimer’s disease in a German family

C. Broeckhoven, M. Cruts, M. Broeck, 2003, Journal of Neurology.

Hereditary Neuralgic Amyotrophy (HNA) is genetically heterogeneous

C. van Broeckhoven, J. Meuleman, B. Falck, 2001, Journal of Neurology.

A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies

G. Assmann, H. Wiebusch, H. Funke, 1997, Neurology.

Norepinephrine transporter (NET) promoter and 5′-UTR polymorphisms: association analysis in panic disorder

M. Nöthen, C. Freitag, R. Fimmers, 2005, Neuroscience Letters.

Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.

M. Friedrich, C. Postert, H. Halfter, 2000, Brain research. Molecular brain research.

Factors Associated with Failure of Reperfusion in Endovascular Therapy for Acute Ischemic Stroke

M. Wiesmann, C. Gerloff, C. Nolte, 2020, Clinical Neuroradiology.

Mutation analysis of 4 candidate genes for hereditary neuralgic amyotrophy (HNA)

C. van Broeckhoven, J. Meuleman, V. Timmerman, 2001, Human Genetics.

A novel missense mutation of the PMP22 gene causing HNPP without generalized electrophysiologic abnormalities

M. Boentert, F. Stögbauer, P. Young, 2004 .